FDA device listing
MCS+8150 Apheresis System
FDA device listing 1772566315 · Haemonetics Corporation
Key facts
| Proprietary names | MCS+8150 Apheresis System |
|---|---|
| Owner/operator | Haemonetics Corporation |
| Owner/operator number | 1219343 |
| Premarket submissions | BK050048 |
| Product codes | GKT |
| Device names | GKT - Separator, Automated, Blood Cell, Diagnostic |
| Device class | Class II |
| Classification regulations (21 CFR) | 864.9245 |
| Review panels | Hematology |
| Registered establishments | HAEMONETICS CORPORATION, Haemonetics Mexico Manufacturing S. de R.L. de C.V. |
| Establishment registrations | 1219343, 9617787 |
| FEI numbers | 1219343, 3003327833 |
| Establishment operations | Manufacturer, Specification Developer |
| Registration valid through | 2026 |
At a glance
- 1–9 Registered establishments listing this device
- 1–9 UDI devices (GUDID) under the same submission
- 1–9 Device listings citing the same submission
- Yes Premarket submission listed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA device listings
Establishments that make or process devices for the U.S. market must list each device with the FDA. A listing records the device's proprietary names, product codes and premarket submission, and every registered establishment that handles it.
Source: U.S. Food and Drug Administration (FDA), Establishment Registration and Device Listing database